|
Volumn 21, Issue 14, 2011, Pages 4337-4342
|
Discovery of a new type inhibitor of human glyoxalase i by myricetin-based 4-point pharmacophore
|
Author keywords
Glyoxalase I; In silico screening; Inhibitor; Pharmacophore modeling; Structure activity relationship
|
Indexed keywords
BENZOTHIAZOLE;
BROMOBENZYLGLUTATHIONE;
CARBOXYL GROUP;
GLUTATHIONE DERIVATIVE;
LACTOYLGLUTATHIONE LYASE;
LYASE INHIBITOR;
MYRICETIN;
TLSC 701;
TLSC 702;
TLSC 703;
TLSC 704;
TLSC 705;
TLSC 706;
TLSC 707;
TLSC 708;
TLSC 709;
UNCLASSIFIED DRUG;
ZINC OXIDE;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
COMPUTER MODEL;
DRUG BINDING;
DRUG INHIBITION;
DRUG SCREENING;
HUMAN;
HYDROGEN BOND;
MOLECULAR DOCKING;
PHARMACOPHORE;
SIMULATION;
BINDING SITES;
CATALYTIC DOMAIN;
COMPUTER SIMULATION;
DRUG EVALUATION, PRECLINICAL;
ENZYME INHIBITORS;
FLAVONOIDS;
HUMANS;
LACTOYLGLUTATHIONE LYASE;
RECOMBINANT PROTEINS;
STRUCTURE-ACTIVITY RELATIONSHIP;
|
EID: 79959864284
PISSN: 0960894X
EISSN: 14643405
Source Type: Journal
DOI: 10.1016/j.bmcl.2011.05.046 Document Type: Article |
Times cited : (31)
|
References (18)
|